Literature DB >> 25600292

Functional genomics of PCOS: from GWAS to molecular mechanisms.

Jan M McAllister1, Richard S Legro2, Bhavi P Modi3, Jerome F Strauss3.   

Abstract

Polycystic ovary syndrome (PCOS) is a common endocrinopathy characterized by increased ovarian androgen biosynthesis, anovulation, and infertility. PCOS has a strong heritable component based on familial clustering and twin studies. Genome-wide association studies (GWAS) identified several PCOS candidate loci including LHCGR, FSHR, ZNF217, YAP1, INSR, RAB5B, and C9orf3. We review the functional roles of strong PCOS candidate loci focusing on FSHR, LHCGR, INSR, and DENND1A. We propose that these candidates comprise a hierarchical signaling network by which DENND1A, LHCGR, INSR, RAB5B, adapter proteins, and associated downstream signaling cascades converge to regulate theca cell androgen biosynthesis. Future elucidation of the functional gene networks predicted by the PCOS GWAS will result in new diagnostic and therapeutic approaches for women with PCOS.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  GWAS; PCOS; genomics; hyperandrogenism; signaling; theca

Mesh:

Year:  2015        PMID: 25600292      PMCID: PMC4346470          DOI: 10.1016/j.tem.2014.12.004

Source DB:  PubMed          Journal:  Trends Endocrinol Metab        ISSN: 1043-2760            Impact factor:   12.015


  86 in total

1.  Persistence pays off for PCOS gene prospectors.

Authors:  Jerome F Strauss; Jan M McAllister; Margrit Urbanek
Journal:  J Clin Endocrinol Metab       Date:  2012-07       Impact factor: 5.958

2.  Ovarian enzyme activities in women with polycystic ovary syndrome.

Authors:  Denis A Magoffin
Journal:  Fertil Steril       Date:  2006-07       Impact factor: 7.329

Review 3.  Polycystic ovary syndrome as a form of functional ovarian hyperandrogenism due to dysregulation of androgen secretion.

Authors:  D A Ehrmann; R B Barnes; R L Rosenfield
Journal:  Endocr Rev       Date:  1995-06       Impact factor: 19.871

4.  Effect of oral contraceptives on markers of hyperandrogenism and SHBG in women with polycystic ovary syndrome.

Authors:  Vincenzo De Leo; Alessandra Di Sabatino; Maria C Musacchio; Giuseppe Morgante; Valeria Scolaro; Antonio Cianci; Felice Petraglia
Journal:  Contraception       Date:  2010-07-16       Impact factor: 3.375

5.  Differential activity of the cytochrome P450 17alpha-hydroxylase and steroidogenic acute regulatory protein gene promoters in normal and polycystic ovary syndrome theca cells.

Authors:  J K Wickenheisser; P G Quinn; V L Nelson; R S Legro; J F Strauss; J M McAllister
Journal:  J Clin Endocrinol Metab       Date:  2000-06       Impact factor: 5.958

6.  Biochemical characterization of the zinc-finger protein 217 transcriptional repressor complex: identification of a ZNF217 consensus recognition sequence.

Authors:  J J M Cowger; Q Zhao; M Isovic; J Torchia
Journal:  Oncogene       Date:  2006-11-27       Impact factor: 9.867

7.  Mutation screening and isoform prevalence of the follicle stimulating hormone receptor gene in women with premature ovarian failure, resistant ovary syndrome and polycystic ovary syndrome.

Authors:  G S Conway; E Conway; C Walker; W Hoppner; J Gromoll; M Simoni
Journal:  Clin Endocrinol (Oxf)       Date:  1999-07       Impact factor: 3.478

8.  Clomiphene citrate resistance in relation to follicle-stimulating hormone receptor Ser680Ser-polymorphism in polycystic ovary syndrome.

Authors:  A Overbeek; E A M Kuijper; M L Hendriks; M A Blankenstein; I J G Ketel; J W R Twisk; P G A Hompes; R Homburg; C B Lambalk
Journal:  Hum Reprod       Date:  2009-04-28       Impact factor: 6.918

9.  Genetic and functional analyses of polymorphisms in the human FSH receptor gene.

Authors:  Satoko Sudo; Masataka Kudo; Shin-ichiro Wada; Osamu Sato; Aaron J W Hsueh; Seiichiro Fujimoto
Journal:  Mol Hum Reprod       Date:  2002-10       Impact factor: 4.025

10.  Genetic alterations within the DENND1A gene in patients with polycystic ovary syndrome (PCOS).

Authors:  Mette B Eriksen; Michael F B Nielsen; Klaus Brusgaard; Qihua Tan; Marianne S Andersen; Dorte Glintborg; Michael Gaster
Journal:  PLoS One       Date:  2013-09-27       Impact factor: 3.240

View more
  54 in total

1.  Perspectives in Polycystic Ovary Syndrome: From Hair to Eternity.

Authors:  Andrea Dunaif
Journal:  J Clin Endocrinol Metab       Date:  2016-02-23       Impact factor: 5.958

Review 2.  Hyperandrogenic origins of polycystic ovary syndrome - implications for pathophysiology and therapy.

Authors:  David H Abbott; Daniel A Dumesic; Jon E Levine
Journal:  Expert Rev Endocrinol Metab       Date:  2019-02-15

3.  Paternal history of diabetes mellitus and hypertension affects the prevalence and phenotype of PCOS.

Authors:  Chen Cheng; Haolin Zhang; Yue Zhao; Rong Li; Jie Qiao
Journal:  J Assist Reprod Genet       Date:  2015-10-06       Impact factor: 3.412

4.  Genetic Predisposition to Polycystic Ovary Syndrome, Postpartum Weight Reduction, and Glycemic Changes: A Longitudinal Study in Women With Prior Gestational Diabetes.

Authors:  Tiange Wang; Junhong Leng; Nan Li; Aline Martins de Carvalho; Tao Huang; Yan Zheng; Weiqin Li; Huikun Liu; Leishen Wang; Gang Hu; Lu Qi
Journal:  J Clin Endocrinol Metab       Date:  2015-10-02       Impact factor: 5.958

5.  The contribution of rare genetic variants to the pathogenesis of polycystic ovary syndrome.

Authors:  Matthew Dapas; Andrea Dunaif
Journal:  Curr Opin Endocr Metab Res       Date:  2020-04-03

6.  Could perturbed fetal development of the ovary contribute to the development of polycystic ovary syndrome in later life?

Authors:  Monica D Hartanti; Roseanne Rosario; Katja Hummitzsch; Nicole A Bastian; Nicholas Hatzirodos; Wendy M Bonner; Rosemary A Bayne; Helen F Irving-Rodgers; Richard A Anderson; Raymond J Rodgers
Journal:  PLoS One       Date:  2020-02-20       Impact factor: 3.240

Review 7.  Emerging Roles of Anti-Müllerian Hormone in Hypothalamic-Pituitary Function.

Authors:  Anne-Laure Barbotin; Maëliss Peigné; Samuel Andrew Malone; Paolo Giacobini
Journal:  Neuroendocrinology       Date:  2019-07-05       Impact factor: 4.914

8.  AMH/MIS as a contraceptive that protects the ovarian reserve during chemotherapy.

Authors:  Motohiro Kano; Amanda E Sosulski; LiHua Zhang; Hatice D Saatcioglu; Dan Wang; Nicholas Nagykery; Mary E Sabatini; Guangping Gao; Patricia K Donahoe; David Pépin
Journal:  Proc Natl Acad Sci U S A       Date:  2017-01-30       Impact factor: 11.205

9.  Gonadal soma controls ovarian follicle proliferation through Gsdf in zebrafish.

Authors:  Yi-Lin Yan; Thomas Desvignes; Ruth Bremiller; Catherine Wilson; Danielle Dillon; Samantha High; Bruce Draper; Charles Loren Buck; John Postlethwait
Journal:  Dev Dyn       Date:  2017-09-25       Impact factor: 3.780

Review 10.  The Pathogenesis of Polycystic Ovary Syndrome (PCOS): The Hypothesis of PCOS as Functional Ovarian Hyperandrogenism Revisited.

Authors:  Robert L Rosenfield; David A Ehrmann
Journal:  Endocr Rev       Date:  2016-07-26       Impact factor: 19.871

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.